OtherAm Heart J · June 2015
This white paper provides a summary of presentations and discussions that were held at an Anticoagulant-Induced Bleeding and Reversal Agents Think Tank co-sponsored by the Cardiac Safety Research Consortium and the US Food and Drug Administration (FDA) at ...
Full textLink to itemCite
https://orcid.org/0000-0001-7123-0100